Kalshi

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?

Resolves Jul 1, 2027

89%chance

– 0.0pt over 23h

Kalshi traders are currently pricing "When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?" at a 89% probability, roughly flat over the last 23h (0 point change).

Volume (24h): $0
Total volume: $4.7K
Liquidity: $0
Open interest: $2.6K
All-time range: 67% – 89%
Our history: 8 days
Resolves: 9mo

How this resolves

If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.

Resolution rules as published by Kalshi — MeleeMarkets doesn't set or interpret these, we just mirror them.

Trade on Kalshi ↗ Compare

Alert me when the odds move

It is at 89% now. Pick the number you care about.

Embed these odds on your site

Paste this where you want the card. It updates by itself and links back here. Add &theme=dark to the address for a dark card.

<iframe src="https://meleemarkets.com/embed.php?m=9375" width="340" height="200" style="border:0;border-radius:16px;max-width:100%" loading="lazy" title="Live odds: When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Heredit…"></iframe>

Odds are mirrored from Kalshi's public market data and may lag the live order book slightly. Informational only — not financial advice. How we source data.

View all

Polymarket

Will the Tesla Roadster's 0-60 time be less than 1 second?

Vol $698.5K today · $5.9M total

100% – 0.0pt

Polymarket

Will the highest temperature in Beijing be 15°C on October 17?

Vol $34.8K today · $35.7K total

0% – 0.0pt

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?

How this resolves

What do you think?

More Other markets